Location: Home
  • search
  • go
  • Relate News
  • 5/1/2025AstraZeneca Faces Escalating Legal Challenges in China Over Drug Impor...
  • 5/1/2025CSL Reviews Potential China Tariff Relief for U.S.-Produced Albumin
  • 5/1/2025China Accelerates Investment in Africa's Burgeoning Pharma Sector
  • 4/30/2025BeiGene Secures Key Patent Victory in Brukinsa Dispute with AbbVie's P...
  • 4/30/2025Escugen and ConjugateBio Announce Exclusive Option Agreement for EZWi-...
  • 4/30/2025Sandoz and Henlius Collaborate to Broaden Oncology Treatment Options
  • 4/29/2025Akeso's BsAb Shows Promising Survival Benefit in Lung Cancer Trial
  • 4/29/2025Qyuns Sets Up Newco for Global Rights to Its Novel Long-Acting BsAb QX...
  • 4/29/2025DualityBio and AstraZeneca Unite to Investigate Novel Lung Cancer Comb...
  • 4/29/2025Innovent Initiates Global Phase 1 Trial for ADC IBI3020
  • 4/29/20253SBio Advances Novel MUC17-Targeting Therapy SSS59 into Global Phase 1...
  • 4/29/2025PegBio Poised for IPO on Hong Kong Stock Exchange Following Successful...
  • 4/29/2025Ribo Life Science Files for IPO on HKSE, Backed by CICC and Citi
  • 4/29/2025CentyMed's Novel EGFR/CD3 BsAb CMDE005 Receives FDA Green Light for Cl...
  • 4/29/2025XellSmart Receives NMPA Approval for Landmark Trial of "On-Demand" iP...
  • 4/29/2025JW and Juno Forge sLVV Licensing Agreement to Advance Cell Therapy Man...
  • 4/29/2025Frontera's Gene Therapy FT-017 Achieves Dual Regulatory Clearance in U...
  • 4/29/2025China's Hospital Drug Market Shows Slight Growth in 2024, Driven by On...
  • 4/29/2025China NMPA Suspends Digoxin API Imports from VITAL LABS
  • 4/29/2025Hengrui Secures Approval for Hong Kong IPO
  • 4/29/2025InnoCare's Orelabrutinib Receives NMPA Approval as First-Line Therapy ...
  • 4/29/2025Innovent Announces NMPA Approval of Limertinib
  • 4/29/2025AmCham China Reports Chinese Tariff Exemptions for Some Pharma Firms A...
  • 4/29/2025Europe Emerges as Key Partner for China Pharma Deals Amid US Market Sh...
  • 4/29/2025ConjugateBio Secures Exclusive Option for Escugen's EZWi-Fit® Platfor...
  • 4/29/2025BeiGene's Novel Cancer Drug Sonrotoclax Seeks Approval in China
  • 4/29/202553 Original Research Drugs Approved in China in Early 2025
  • 4/29/2025State Council Approves Draft Medical Security Law, Strengthening Fund ...
  • 4/29/2025China Orders Drugmakers, Hospitals to Study US Import Replacements
  • 4/29/2025AstraZeneca's China Business Recovers in Q1 2025 Amid Easing Regulator...
  • Page:1/764 Total number of articles:22892: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group